Explorer les evidences

1,6 %The prevalence of hepatitis C virus (HCV) in the study population was 1.6%.

Nigeriahépatite Cpublié 2025American journal of clinical pathologyPubMeddocument de 5 observations

2,23 %The overall prevalence of transfusion transmissible infections over the 6-year period for all donors at LUTH was 2.23% for HCV.

Nigeriahépatite Cpublié 2021West African journal of medicinePubMeddocument de 7 observations

2,9 %HCV prevalence among study participants was 2.9%.

Nigeriahépatite Cobservé 2009-12publié 2016PloS onePubMeddocument de 14 observations

0,11 %Among 2775 pregnant women in Nigeria, the seroprevalence of HBV-HCV dual infection was 0.11%.

Nigeriahépatite B · hépatite Cpublié 2025Antiviral therapyPubMeddocument de 7 observations

4,4 %The prevalence of HCV infection among HIV-infected people in Port Harcourt, Rivers State was 4.4%.

Nigeriahépatite C · VIH/sidapublié 2021African health sciencesPubMeddocument de 4 observations

2,25 %The seroprevalence rate for hepatitis C virus among blood donors at the Lagos University Teaching Hospital in Nigeria was 2.25% over the 2015–2019 period.

Nigeriahépatite Cobservé 2015-2019publié 2022British journal of haematologyPubMeddocument de 7 observations

1,8 %The prevalence of hepatitis C virus (HCV) among antenatal women at the 68 Nigerian Army Reference Hospital in Lagos was 1.8%.

Nigeriahépatite Cpublié 2022West African journal of medicinePubMeddocument de 6 observations

HIV mono-infected patients had significantly lower alanine aminotransferase levels compared to HIV/HCV co-infected study participants.

Nigeriahépatite C · VIH/sidapublié 2021Annals of African medicinePubMeddocument de 3 observations

2,57 %Among HIV-positive patients aged 31–40 years in the study, the prevalence of HIV/HCV co-infection was 2.57%.

Nigeriahépatite C · VIH/sidaobservé 2019publié 2020Journal of immunoassay & immunochemistryPubMeddocument de 9 observations

21,4 %HCV prevalence was 21.4% among middle-income individuals at the Federal Medical Center, Makurdi.

Nigeriahépatite Cpublié 2024BMC public healthPubMeddocument de 7 observations

3,2 %The hepatitis C prevalence in conflict zones in Nigeria was 3.2%.

Nigeriahépatite Cobservé 2018publié 2021Annals of global healthPubMeddocument de 12 observations

22 %46 out of 213 subjects had active hepatitis C, representing 22%.

Nigeriacarcinome hépatocellulaire · hépatite Cobservé August 2018 to November 2021publié 2023PloS onePubMeddocument de 9 observations

0,64 %Among HIV-positive patients in the study, the prevalence of HIV/HBV/HCV triple infection was 0.64% among females and 0% among males.

Nigeriahépatite B · hépatite C · VIH/sidaobservé 2019publié 2020Journal of immunoassay & immunochemistryPubMeddocument de 9 observations

14,7 %Among female diabetic subjects, HCV seropositivity was 14.7%.

Nigeriahépatite Cpublié 2020BMC infectious diseasesPubMeddocument de 7 observations

750 US$Commodity costs for a 12-week pan-genotypic direct-acting antiviral regimen for hepatitis C virus fell from US$750–US$900.

Nigeriahépatite Cpublié 2020BMJ global healthPubMeddocument de 6 observations

13,8 %The second most identified risk factor for hepatitis C virus infection among pregnant women in Nigeria was shared needles, reported by 13.8% of participants.

Nigeriahépatite Cpublié 2021Women's health (London, England)PubMeddocument de 7 observations

3,86 %The prevalence of HIV/HCV co-infection among HIV-positive patients attending three major hospitals in the Federal Capital Territory, Nigeria was 3.86%.

Nigeriahépatite C · VIH/sidaobservé 2019publié 2020Journal of immunoassay & immunochemistryPubMeddocument de 9 observations

4,7 %Hepatitis C had a prevalence of 4.7% in 2020 among blood donors in Osun State.

Nigeriahépatite Cobservé 2020publié 2025BMC infectious diseasesPubMeddocument de 17 observations

48,4 %Awareness of hepatitis C virus infection among pregnant women in Nigeria was 48.4%.

Nigeriahépatite Cpublié 2021Women's health (London, England)PubMeddocument de 7 observations

18,9 %Among alcoholic-consuming diabetic subjects, HCV seropositivity was 18.9%.

Nigeriahépatite Cpublié 2020BMC infectious diseasesPubMeddocument de 7 observations

1,73 %The overall hepatitis C positivity rate in Nigeria was 1.73%.

Nigeriahépatite Cobservé 2018publié 2021Annals of global healthPubMeddocument de 12 observations

2,57 %Among HIV-positive patients in the study, the prevalence of HIV/HCV co-infection was 2.57% among females and 1.29% among males.

Nigeriahépatite C · VIH/sidaobservé 2019publié 2020Journal of immunoassay & immunochemistryPubMeddocument de 9 observations

0,6 %Dual seropositivity of anti-hepatitis C virus/hepatitis B surface antigen among pregnant women in Nigeria accounted for 0.6%.

Nigeriahépatite B · hépatite Cpublié 2021Women's health (London, England)PubMeddocument de 7 observations

22,5 %Among diabetic subjects aged 41–50 years, HCV seropositivity was 22.5%.

Nigeriahépatite Cpublié 2020BMC infectious diseasesPubMeddocument de 7 observations

11,3 %The third most identified risk factor for hepatitis C virus infection among pregnant women in Nigeria was blood transfusion, reported by 11.3% of participants.

Nigeriahépatite Cpublié 2021Women's health (London, England)PubMeddocument de 7 observations